Menopause. One of probable causes of imparement of ovarian functions in menopause is reduction in the number of gonadotrophin receptors in them resulting in gradual decrease in production of estradiol, progesterone, androstenedione and testosterone and reduction in the size of ovaries which become 2-3 times smaller. Impairment of hormonal functions of female reproductive system leads to development of such complications as atrophic vaginitis, urocystic disorders and osteoporosis. Start of menopause entails hormonal readjustments in female organism resulting in changes in lipid metabolism inducing development of atherosclerosis.
The basis of treatment in complicated climacteric syndrome is hormonal therapy, which is contraindicated incase of bloody vaginal discharge.
EnergoIod preparations show the following effects in menopause:
- regulation of metabolism;
- normalization of the functions of thyroid gland;
- regulation of endocrine profile allowing to endure impaired function of reproductive hormones easier;
- prevention of tumors in female reproductive system;
- EnergoIod has anti-inflammatory, immunomodulatory and regenerative effects;
- EnergoIod has antioxidant, fibrinolytic, antiaggregant and secondary analgetic effects;
- Improvement of functions of nervous system due to effect on endocrine glands.
Thus EnergoIod shows complex preventive effect on female organism as a whole and protects against many troubles.
Use of EnergoIod in this disease
Use of EnergoIod in this disease
Weight, kg
For disease
Lung disease
Average disease
Severe disease
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
40
2
4
4
8
6
12
50-60
3
6
6
12
9
18
70-80
4
8
8
16
12
24
90-100
5
10
10
20
15
30
110-120
6
12
12
24
17
34
Use of a concentrate
Shake before use. It requires dilution with cold or cool drinking water (in an amount of 100-200 ml).
The daily dose calculated for 1 kg body weight, depending on the severity and course of the disease is 0.1-0.3 ml / kg body weight / day, divided into 2 doses.
The drug is taken on an empty stomach in the morning and in the evening before going to bed for 30 days.
If necessary, a second course in 15 days.
The number of courses per year depending on the severity of the pathological process.
Carrying out an accelerated rate with the maximum dose for 15 days.